Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Arjo announces date of 2020 Q3 report and conference call

Arjo will issue its Q3 report for 2020 on Wednesday October 28 at 07:00 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Daniel Fäldt, CFO. We invite fund managers, analysts and the media to participate in the conference call. Please see details below to join the conference.  Swedish dial-in number: +46 8 519 993 83USA: +1 833 526 8383UK: +44 3333 009 266 During the telephone conference, a presentation will be held. To access the presentation, please use this link: https://tv.streamfabriken.com/arjo-q3-2020 Alternatively, use

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 71 - 14 OCTOBER 2020 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, Motortramp A/S continuously sells shares pro rata and the market is to be informed accordingly – see the attached file. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451Anne-Louise Dam-Rasmussen, Head of Communications, tel.: +45 3273 0624

Industrial plastics were recycled with enthusiasm

Kaarea and Oral Hammaslääkärit have joined Kiilto’s development project and started recycling plastic materials they use. A follow-up to the successful pilot project is already in the works.Spaghetti bolognaise is being prepared today at the Turku University Hospital nutrition centre. Special diets are catered for with separate foods, such as pureed soups that are easier to swallow. Kaarea employees, who are responsible for the hospital’s food service, also prepare the meals for the staff canteen. According to Kaarea service manager Sanna Lainela, special attention is naturally paid to

Nextory's customer base continues to grow - revenues have increased by 76 percent

The book service Nextory has left another strong quarter behind. This year, the company's revenues have so far increased by 76 percent compared to the same nine months last year. Thereby, Nextory continues its rapid growth and has once again broken a new record of new subscribers during one month. Nextory's customer base has continued to grow rapidly during the third quarter of the year and the growth has been strong both in Sweden and in the company's foreign markets. In July, the company also set a new record in new subscribers during one month. Also, the number of new customers

Budding collaboration between Spira and Elvenite

In August, Elvenite launched a collaboration with a new customer in the ERP business area, Spira Blommor AB. Since last year Spira is a part of the dutch Groenland Group, one of the main actors in the floriculture sector in Europe. Spira has a penchant for making people’s everyday lives a little more beautiful by delivering fresh flowers to our most visited stores – the grocery stores.– The collaboration with Elvenite is working very well and has been since day one. The greatest take away from this project is that we will be set up with our separate business system, as opposed to sharing

Nokian Tyres will publish its Interim Report January–September 2020 on October 27, 2020

Nokian Tyres plc Press Release October 14, 2020, 10:00 a.m. Nokian Tyres will publish its Interim Report January–September 2020 on October 27, 2020 approximately at 2:00 p.m. Finnish time. After publication, the release and presentation material will be available on the company's website at www.nokiantyres.com/company/investors/ Conference call A conference call for investors, analysts and media will be held on October 27, 2020 at 3:00 p.m. Finnish time. In the call, President and CEO Jukka Moisio and CFO Teemu Kangas-Kärki will present the financial results. To participate, please

BioStock: Immunicum updates clinical development strategy

Since bringing in Sven Rohmann as new CEO in August, Immunicum has updated its clinical development strategy to include four major pillars aimed at delineating the best way to market. In addition, the company presented positive preclinical data at ESMO 2020 last month, showing that the its off-the-shelf immuno-oncology treatment ilixadencel strengthens the efficacy of existing immunotherapies.Read the full article at biostock.se: https://www.biostock.se/en/immunicum-updates-clinical-development-strategy/ This is a press release from BioStock - Connecting Innovation & Capital. https://

Motion Display awarded 7,5 MSEK order

The success of Motion Display in the US continues, and the company has received a new large order. The order is worth 7,5 MSEK.A leading US supplier of personal care products has placed an order worth 7,5 MSEK. The order includes displays and installation at two leading nationwide drugstore chains. Delivery will take place during the fourth quarter of 2020. “It is extra rewarding that this is a repeat customer who decided to deploy our displays outside Walmart for the first time. This increases the volume as we are reaching substantially more stores. Expanding Motion Display programs to

NOTICE OF EXTRA GENERAL MEETING IN ENAD GLOBAL 7 AB (PUBL)

The shareholders of Enad Global 7 AB (publ), reg. no. 556923-2837, (the "Company") are hereby invited to the extra general meeting on Thursday 29 October 2020 at 10.00 a.m. CET at Baker & McKenzie's premises at Vasagatan 7 in Stockholm. The doors to the meeting will open at 09.45 a.m. CET. Information with respect to the coronavirus Due to the development of the coronavirus the goal is that the general meeting shall be swift and effective to minimize spread of disease. Shareholders should carefully consider the possibility to vote in advance, please see below, as well as the

Follicum obtains patent in the United States for the company's peptides for the treatment of diabetes and related complications

Follicum AB  announced today that the patent which previously (June 22, 2020) received a so-called Notice of Allowance from the US Patent and Trademark Office ("USPTO") has now also been formally approved by the authority. The patent is called "Peptides for Treatment of Diabetes" and the patent will be valid until 2038.The patent (US 10815283) covers peptides from the company's two peptide classes and their use in the treatment of diabetes and its complications. The patent will be formally approved on October 27, 2020. CEO Jan Alenfall comments: "The US is by far the largest market

BioStock: High expectations on a deal for Respiratorius

In June, Respiratorius raised just over SEK 25 million in a heavily oversubscribed rights issue. The capital will, among other things, be allocated to finance remaining preparations for a phase III study with cancer candidate VAL001. As the study looms, expectations of a partnership agreement intensify. Speculation increased even further after the company received the recommendation from the European Medicines Agency to go directly to Phase III without conducting a Phase IIb study.Read the full article at biostock.se:https://www.biostock.se/en/high-expectations-on-a-deal-for-respiratorius/

Invitation to presentation of results for third quarter 2020

14 October 2020 – Kværner ASA’s results for the third quarter 2020, will be published through the Oslo Stock Exchange on Wednesday 28 October 2020 at 07:00 CET.A presentation will be held at Akerkvartalet, Oksenøyveien 10 at 09:00 CET the same morning. To attend the presentation, please register by emailing ir@kvaerner.com The presentation will be broadcast live on www.kvaerner.com and https://channel.royalcast.com/webcast/hegnarmedia/20201028_4/ at 09:00 CET. The complete 3rd quarter results 2020 presentation will be available at www.kvaerner.com and www.newsweb.no. ENDS

K-Fast Holding AB’s Nomination committee for the 2021 Annual General Meeting

The Nomination committee of K-Fast Holding AB has been appointed.According to the instructions for the Nomination committee adopted at Extra General Meeting on 19 August 2019, the Nomination committee shall consist of four members, representing the three largest shareholders as of 30 September, together with the Chairman of the Board. If a shareholder, who is entitled to appoint a representative to the Nomination committee, abstains from appointing a representative, the right to appoint a representative shall pass to the largest shareholder who was previously not entitled to appoint a

Mellifiq secures an investment from consortium led by Anders Jacobson and acquires Ozonetech

Today Mellifiq announced that it has raised a significant investment amount together with internationally recognized impact investor Anders Jacobson to speed up its international expansion for market-leading environmental solutions. Mellifiq is an environmental service company that recently acquired several well-known brands such as Ozonetech which complements its offering of water filtration and industrial air solutions. Ozonetech’s portfolio consists of cutting-edge engineered products and unique solutions for air and water treatment based on advanced oxidation technologies. The

SAS launches new shareholder program

SAS shareholders are an important part of the company’s future. SAS consequently launches a new shareholder program with exclusive travel benefits for shareholders that are EuroBonus members and own more than 4 000 shares.All shareholders that are EuroBonus members and owners of more than 4 000 shares on November 30, 2020, are eligible to join the shareholder program. Members of the program will receive the campaigns provided to SAS employees 2-3 times a year, with heavily discounted prices on selected domestic and international air fares. Shareholders with 100 000-1 million shares by

Gasum study shows that Finnish power system can take up to 30 TWh of wind power

Commissioned by the Finnish Wind Power Association, Gasum studied how much weather-dependent variable wind power the Finnish power system could take in 2030. The study showed that the Finnish power system could take as much as 25-30 terawatt hours (TWh). The study findings support the Finnish Wind Power Association’s aim of wind power meeting 30% of Finland’s electricity consumption at the turn of the next decade. Gasum is a major actor in the wind power segment and strives to increase the procurement renewable wind power in the Nordic countries.Commissioned by the Finnish Wind Power

Online horse race bettors are less keen to gamble after a losing day

A new study from the University of Eastern Finland shows that a bettor likely stays away from betting for a 27% longer time after a losing day than after a day on which they won or broke even. The study looked at how losing or winning on the previous betting day predicts how long it takes from a bettor to return to the next session of online horse race betting. The study also found that high wins or losses on the previous betting day do not predict the timing of the next betting session. “A typical online horse race bettor seems to modify their betting behaviour according to how

SSM has received a public offer from Amasten

Amasten Fastighets AB (publ) (”Amasten”) has today announced a public offer to the shareholders in SSM Holding AB (publ) (”SSM”). The offer includes the tendering of all outstanding shares in SSM for a consideration of 1.20 new ordinary shares in Amasten for each existing share in SSM, corresponding to6 new ordinary shares in Amasten for 5 existing shares in SSM (the “Offer”).The Offer in summary · Amasten offers 1.20 new ordinary shares in Amasten for each existing share in SSM,corresponding to 6 new ordinary shares in Amasten for 5 existing shares in SSM. · The Offer values

ABGSC – Q3 2020 Interim Report

Highlights from the quarter:-  Strong momentum continues as Q3 Revenues are up 34% and Diluted EPS is up 86% y-o-y-  Revenues YTD up 22% to NOK 1,033m (848m)-  Diluted EPS YTD up 33% to NOK 0.32 (0.24)-  Interim dividend of NOK 0.17 per share-  High activity at the start of Q4 CEO comment:“Q3 proved to be yet another solid quarter for ABGSC. While it is normally the seasonally slowest quarter, we managed to achieve the strongest third quarter result since 2007 and the second best since the company was listed, almost 20 years ago. We continue to gain market share in an already

AcadeMedia’s Compulsory School Segment clarifies pedagogic offer and launches new educational profiles

In 2011 AcadeMedia acquired “Pysslingen förskolor och skolor”, a group of well-run pre- and compulsory school units with a variety of pedagogics. AcadeMedia’s Compulsory School Segment will now take steps to provide clarity on the differences between the existing units, grouping those with similar pedagogies and governance under the same educational profile.   This shift will result in 28 of the Pysslingen Skolor branded units will change their names – 22 to Noblaskolan and six to Montessori Mondial. This change will occur 14 October 2020. AcadeMedia’s Compulsory School Segment is run

New granted reservation permit for exploration in Finland

Eurobattery Minerals AB (Nordic Growth Market: "BAT"; “the Company”) a growth company in the mining and exploration industry with the vision to help Europe become self-sufficient in ethical battery minerals, today announces that FinnCobalt Oyj (formerly Vulcan Hautalampi Oy) has informed the Company about its expansion in eastern Finland with a new granted reservation permit for exploration over the highly prospective Hietajärvi Project (“the Project”). The Project covers over 289km[2] of ground highly prospective for cobalt, copper, nickel and zinc deposits. Eurobattery Minerals has the

Moberg Pharma intends to submit a registration application in Europe in 2021

STOCKHOLM, October 14[th], 2020, Moberg Pharma AB (OMX: MOB) announced today its decision to request pre-submission meetings with regulatory agencies, with the goal of submitting a registration application in the second half of 2021 in Europe.In June, Moberg Pharma presented topline results from the second of two clinical Phase 3 studies for MOB-015. In the European study – as well as in the North American study – the primary endpoint was achieved and no serious adverse events were reported. MOB-015’s superior mycological cure (percentage of patients who were fungus free) has now been

New publication in high-impact scientific journal PNAS confirms the bone regenerative potential of OssDsign’s technology.

A scientific article titled “In situ bone regeneration of large cranial defects using synthetic ceramic implants with a tailored composition and design” was recently published in the scientific journal PNAS (Proceedings of the National Academy of Sciences of the United States of America). The research article describes how OssDsign’s unique implant concept and proprietary material composition promote bone regeneration and osseointegration.OssDsign AB (publ) (“OssDsign”) today announced that a scientific article with the title “In situ bone regeneration of large cranial defects using

Interim Report for the period January – September 2020

An additional Phase 3 study in Alzheimer’s diseaseKey events during the third quarter 2020 · BioArctic’s partner Eisai has started an additional global clinical Phase 3 program (AHEAD 3-45) to evaluate the effect of BAN2401 in individuals who have not yet developed symptoms of Alzheimer’s disease but have intermediate or elevated amyloid levels in the brain. · Eisai presented new data regarding BAN2401 from the open-label extension study at the Alzheimer’s Association International Conference® (AAIC). The data indicated a rapid and continual reduction in amyloid levels in the brain

There are no items matching the current filter
There are no more items matching the current filter
Back to top